Similar outcome of heart failure with reduced EF patients with and without atrial fibrillation: considerations from the ESC Heart Failure Long-Term Registry

Submitted: March 15, 2019
Accepted: July 4, 2019
Published: September 10, 2019
Abstract Views: 1026
PDF: 672
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Recently, transcatheter ablation of atrial fibrillation (AF) has been validated by international societal guidelines as a technique suitable for both treatment and secondary prevention of paroxysmal, persistent or long-lasting persistent AF in highly symptomatic patients in whom at least one antiarrhythmic drug had been tested.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

How to Cite

De Vecchis, Renato. 2019. “Similar Outcome of Heart Failure With Reduced EF Patients With and Without Atrial Fibrillation: Considerations from the ESC Heart Failure Long-Term Registry”. Monaldi Archives for Chest Disease 89 (3). https://doi.org/10.4081/monaldi.2019.1061.